Quintiles Library

Tom Pike on Opening Bell
Featured Brochure

Quintiles CEO Tom Pike Appears on Fox Business Networks Opening Bell
On Wednesday, September 10th, Quintiles CEO Tom Pike appeared on the Fox Business Network’s “Opening Bell,” television program hosted by Maria Bartiromo (video below). Tom also talked with Maria’s co-host for the day, Bob Nardelli, former CEO of Home Depot and Chrysler. During the appearance, Tom explained Quintiles’ business model and how we work with biopharma customers. Additional topics included Quintiles Infosario Design and genomics services provided through...


















































































Remove allSelected Topics:
    Video
    Dr. Dennis Gillings, CBE, World Dementia Envoy, discusses the global burden of Alzheimer’s disease and how the G7 is driving new public-private efforts to drive new research into innovative prevention and therapy approaches to the disease. This is the player to use for single videos on Q.com ...
    Fact Sheet
    On July 9, 2014, Paula Brown Stafford, president of Clinical Development at Quintiles, was invited to provide expert testimony in a U.S. Congressional hearing on the topic of modernizing clinical trials. During the hearing, Stafford provided recommendations and possible approaches Congress could take to address issues in three key areas – patients, processes and pathways – to accelerate the delivery of therapies to patients.  Download this fact sheet for a summary of Quintiles’ recommendations to Congress and what we’re doing today to help address the key challenges we all face in improving the productivity of clinical...
    Read More
    Fact Sheet
    Convert your fixed costs to variable, minimize long-term risk, increase operational efficiencies, and flexibly respond to changing market dynamics, with our commercial services, to help improve your probability of success. Depending on your needs, you can choose those services or solutions, customizable to your short and long-term...
    Read More
    White Paper
    Market access now demands closer collaboration between biopharma, payers and providers. In a climate where ongoing reimbursement of a drug relies on biopharma’s ability to demonstrate how it delivers value to the entire healthcare system, partnership working is essential. Outcomes audits should be seen as one of the most important tools available to biopharma. They deliver detailed action plans to both biopharma and the NHS, proposing improvements to the care pathway aimed at delivering real value to the entire healthcare system. By downloading “Harnessing vital data to inform an optimal market access strategy in the UK” you will gain: A comprehensive overview of outcomes audits and their place in UK market access.  A strong understanding of the benefits an audit delivers to both...
    Explore More
    Fact Sheet
    Selecting the right development partner comes down to priorities.  Having worked for over 240 emerging biopharma customers since 2009, we’ve learned about your distinct challenges...
    Read More
    Video
    On Wednesday, September 10th, Quintiles CEO Tom Pike appeared on the Fox Business Network’s “Opening Bell,” television program hosted by Maria Bartiromo (video below). Tom also talked with Maria’s co-host for the day, Bob Nardelli, former CEO of Home Depot and Chrysler. During the appearance, Tom explained Quintiles’ business model and how we work with biopharma customers. Additional topics included Quintiles Infosario Design and genomics services provided through Expression Analysis. Much of the interview centered on Quintiles’ product development work and the ways in which we help pharma reduce costs and speed up timelines within drug development and commercialization. This is the player to use for single videos on Q.com ...
    Fact Sheet
    Ahora puede reducir, de principio a fin, la carga administrativa que conlleva la investigación clínica. Quintiles Infosario Site Gateway le da acceso, en un práctico espacio de trabajo en línea, a datos centralizados para sus estudios gestionados por Quintiles. Dado que Quintiles utiliza este mismo sistema para la identificación y selección del centro de investigación, usted puede actualizar su perfil directamente en esta plataforma en línea, para asegurarse de que se comuniquen con usted, para ofrecerle las oportunidades de estudio que mejor se ajusten a sus posibilidades. El hecho de usar esta misma información le permite rellenar formularios de información de su centro para acelerar su respectiva...
    Read More
    Video
    Badhri Srinivasan, Senior Vice President and Head, Global Data and Safety Monitoring at Quintiles, discusses how Clinical Data Management (CDM) is making a move from the more traditional activity-based or “data curator” role to a very critical “information based” role.In this short video, Srinivasan discusses with some other senior leaders at Quintiles how it has quickly become an industry requirement that CDM teams must not only maintain data integrity, but also interpret data, identify signals and better predict trial outcomes through a more rigorous medical analysis – which will ultimately transform clinical development and improve our customers’ probability of success. This is the player to use for single videos on Q.com ...
    Fact Sheet
    With nearly 1% of the world's population affected by rheumatoid arthritis, you need one global partner to support your research from discovery to post-market. Learn about how our clinical resources and global labs have helped us develop or commercialize the top 40 rheumatology drugs of...
    Read More
    Fact Sheet
    Quintiles Infosario Site Gateway enables sites to easily manage time-consuming clinical trial tasks. With our single user-friendly system, sites can take advantage of a wide range of services, transforming clinical development. With Quintiles Infosario Site Gateway, you can empower your sites with an award-winning online workspace that provides secure on-demand access to the right information. The result? Quicker decision-making for more efficient project delivery — and, ultimately, better patient outcomes. And with greater visibility into centralized site performance data, Quintiles can help select the right sites for your...
    Read More
    Fact Sheet
    Learn about how our clinical resources and global central labs have helped us develop or commercialize the top 45 oncology drugs of...
    Read More
    Fact Sheet
    Infosario Safety platform is a comprehensive, cloud-based safety system that increases your agility and cost efficiency. Infosario Safety is designed to manage your safety activities across all your programs, decrease information technology investment and streamline...
    Read more
    Media Coverage
    Jeremy Broadis, Vice President, Commercial Solutions looks at how specialist pharma companies can evaluate a number of options when considering the sometimes daunting prospect of launching their product in...
    Read more
    Media Coverage
    John Procter, Senior Director, Value and Access, says the industry must increasingly prove how products can improve patient outcomes, and adapt its offering to...
    Read more
    Fact Sheet
    As Inflammatory Bowel Disease (IBD) severity increases in patients entering studies, trial design is becoming more complex – and finding the right patients is a continuing challenge. Higher risk profiles of new biologics are forcing a tighter focus on safety issues, and market attractiveness is driving strong competition. So how can drug developers successfully overcome the myriad challenges you face? As a market leader in conducting IBD studies across the lifecycle and around the globe, Quintiles has the experience and therapeutic and operational expertise to help you take your IBD therapy from lab to...
    Read more
    Fact Sheet
    In this edition, we will look specifically at Latin America. Despite cultural and linguistic similarities among the countries in this region, there are notable socioeconomic differences which are reflected in a variety of health systems. Consequently, different countries are also at different stages in HTA implementation as well as expertise. Click the download button above to read the May...
    Read more
    Fact Sheet
    For one of the most mature markets in the world, Japan continues to offer huge opportunities for growth. It is the largest pharmaceutical market in the Asia Pacific region and second only to North America worldwide. With government healthcare reforms spurring innovation, Japan equals the promise of emerging countries without the risk. Quintiles’ integrated teams, backed by our global standards, processes and technology, provide the expertise you need to confidently develop and market therapies in Japan. Whether you’re looking to enter Japan only or the larger Asia Pacific market, trust Quintiles to help deliver on your globalization...
    Read more
    White Paper
    Rising costs, increased pressures and heightened expectations have fostered an environment of risk and uncertainty in the drug development and delivery market. The question now is – How can the industry transform itself to thrive in this new era of...
    Explore here